Study S000394

Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01937598
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: COMPLETED
Enrollment: 16
Start: 2013-08
Primary completion: 2014-04
Lead sponsor: Michael A. Nauck
Conditions: Type 2 Diabetes
Interventions: DRUG:Placebo; OTHER:Mixed meal test; DRUG:Liraglutide; DRUG:Sitagliptin
Results posted: TRUE
Individual participant data sharing: UNDECIDED
Secondary identifiers: EUDRACT_NUMBER:2013-001764-35

Registered primary outcomes

Incremental Area Under the Plasma Glucose (BG) Concentration-time Profile (AUC) [0 to 300 min post mixed meal test]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.